Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

247.92
-0.4695-0.19%
Number of Gainers:4
Number of Losers:12
Number of Flat:- -
PE:- -
High:249.17
Open:248.48
Low:245.46
Close:248.39
Volume:16.94M
Turnover:239.19M
Market Cap:61.21B
Float Cap:53.96B

Loading ...

Update: Teva, Samsung Bioepis Partner to Develop, Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Oct 02

Aurora UK Alpha Schedules 2026 Investor Event to Highlight Value Strategy

TIPRANKS
·
Oct 02

Aurora World Declares Quarterly Cash Dividend for Common Shareholders

TIPRANKS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Zentek (OtherZTEKF) and Dr Reddy’s Laboratories (RDY)

TIPRANKS
·
Oct 01

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Oct 01

AIM ImmunoTech Says Phase 2 Duripanc Pancreatic Cancer Trial Advances Toward Q1 2027 Topline Data

Reuters
·
Oct 01

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as Duripanc Advances Toward Topline Data

THOMSON REUTERS
·
Oct 01

Teva initiated with a Buy at TD Cowen

TIPRANKS
·
Oct 01

Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 01

Aurora Energy Metals Sets AGM Date and Opens Director Nominations

TIPRANKS
·
Oct 01

Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness

Dow Jones
·
Oct 01

Cannabis Stocks are Slumping. a Procedural DEA Delay is to Blame.

Dow Jones
·
Oct 01

Aurora UK Alpha Updates Capital Structure After Share Buyback

TIPRANKS
·
Oct 01

Can Brewdog get ‘equity punks’ onside in bid to move on from James Watt?

cityam
·
Sep 30

AIM ImmunoTech Expects Q1 2027 Topline Data from Phase 2 Duripanc Trial of Ampligen Plus Durvalumab in Metastatic Pancreatic Cancer

Reuters
·
Sep 30

Harrow to Present Phase 3 Byqlovi Post-Cataract Inflammation Trial Data at AAO 2026

Reuters
·
Sep 30

10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher

GlobeNewswire
·
Sep 30

Dr. Reddy's Laboratories Slides Wednesday, Underperforms Market

Dow Jones
·
Sep 30

Aurora Energy Metals Details ASX Corporate Governance Compliance for FY 2026

TIPRANKS
·
Sep 30